SGO on the GO

Episode two of the Radiation Therapy podcast series discusses treatment of Oligometastatic disease, re-irradiation and role of palliative radiation, utilization of SBRT, introduction to proton therapy and mitigation of radiation-associated toxicities.

Host:
Mian M. Shahzad, MD, PhD
Gynecologic Oncologist, H. Lee Moffitt Cancer Center

Guest Speaker: 
Michael Montejo, MD
Radiation oncologist, H. Lee Moffitt Cancer Center 

This episode is part 1 of the Immunotherapy podcast series, which reviews immune-checkpoint inhibitors encountered in the gynecologic oncology setting, common immunotherapy toxicities and patient counseling on them, as well as the basic treatment course for patients with high-grade toxicities.

Moderator:
Karin K. Shih, MD
Gynecologic Oncologist & Assistant Professor - Zucker School of Medicine at Hofstra/Northwell

Speakers: 
Erin Zacholski, PharmD, BCOP 
Assistant Professor - VCU School of Pharmacy
Clinical Pharmacy Specialist, Gynecologic Oncology -  VCU Health Massey Cancer Center
 
Sarah Hayward, PharmD, BCOP
Clinical Pharmacy Specialist, Gynecologic Oncology - OU Health Stephenson Cancer Center

This episode is part 1 of the Radiation Therapy podcast series, which looks to review and address the basic fundamentals of radiation therapy in the gynecologic oncology setting.

Host: Mian M. Shahzad, MD PhD (Gynecologic Oncologist; H. Lee Moffitt Cancer Center)

Guest Speaker: Michael Montejo, MD (Radiation oncologist; H. Lee Moffitt Cancer Center) 

This is the last of the three-part podcast series, Keeping up with the Chemos on Trametinib. Our multidisciplinary panel will discuss the challenges with patient monitoring while on Trametinib. When to dose adjust and hold or even discontinue Trametinib. Once again, the podcast ends with take home points for patient monitoring and side effects while on Trametinib. 

2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:
Tracilyn Hall, MD
Jennifer MacDonald, PharmD, BCOP

Speakers:
Christina M. Davis, PharmD, BCOP
David M. Gershenson, MD 
Rebecca L. Porter, MD, PhD 

This is the second of the three-part podcast series, Keeping up with the Chemos on Trametinib. Our multidisciplinary panel will discuss the important information about the drug preparation and administration of Trametinib. Focusing on oral dosing, lab examinations, prophylactic management of skincare reactions, and patient education. The session ends with general take home points on administration and toxicity prevention interventions.

2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:
Tracilyn Hall, MD
Jennifer MacDonald, PharmD, BCOP

Speakers:
Christina M. Davis, PharmD, BCOP
David M. Gershenson, MD 
Rebecca L. Porter, MD, PhD 

This is the first of the three-part podcast series, Keeping up with the Chemos on Trametinib. After going over some general information on Trametinib including mutation status considerations, baseline lab testing, ocular toxicity, and line of therapy. The multidisciplinary panel will discuss dosing and drug preparation for giving Trametinib. The session wraps up with some key take home points on Trametinib.

2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:
Tracilyn Hall, MD
Jennifer MacDonald, PharmD, BCOP

Speakers:
Christina M. Davis, PharmD, BCOP
David M. Gershenson, MD 
Rebecca L. Porter, MD, PhD 

The goal of this podcast is to continue our series on key concepts of enhanced recovery after surgery (ERAS). In September 2022, the SGO Education Committee's ERAS Subcommittee discussed why we do it, and in February 2023, we talked about how we do it. This podcast will complete our trilogy and discuss implementation or looking at how well we do it.

Listen to Gregg Nelson, MD, PhD from the University of Calgary discuss ERAS implementation including some of the starting points, his experience in his own institution, and key ERAS lessons learned.  Dr. Nelson is the Deputy Head of the Department of Obstetrics & Gynecology at the Cumming School of Medicine in Calgary, Alberta, Canada and is Chief of Gynecologic Oncology at the Tom Baker Cancer Centre. He is also on the Executive Committee for the international ERAS® Society, and a lead author for the ERAS® Society gynecologic guidelines.

2023-2024 ERAS Subcommittee Moderator and Podcast Script Editor:
Lee-may Chen, MD

2022-2023 Opioid/ERAS Subcommittee Members:
Jing-Yi Chern, MD (Moderator)
Amanika Kumar, MD (Podcast Script Editor)

Podcast Invited Speaker:
Gregg Nelson, MD, PhD 

Let’s face it, wellness is an ever-evolving concept. Listen in as we celebrate aspects of wellness throughout the SGO community. These are 10–20-minute quarterly snippets to highlight the authentic voices from SGO and beyond. Stay connected and foster community in between SGO meetings. You can find these episodes anywhere you get your SGO on the Go podcasts.

To view the SGO Wellness Curriculum, click here. 

Join Dr. Kathryn Mills as she interviews Drs. Jubilee Brown, Ann Klopp, Joyce Liu, and Jyoti Mayadev to discuss the latest NRG Oncology updates on upcoming studies, research, and trials. The focus for the podcast is to bridge the gaps between SGO members and NRG Oncology.  

Some questions covered during the interview:

1. What are some of the upcoming trials in your disease site that you are most excited about?
2. What advice would you give sites considering opening some of the trials that are available?
3. How can sites get more efficient at screening and enrollment?
4. How can sites increase enrollment of minorities?

This episode was created by Dr. Kathryn Mills, a former 2022-2023 member of the SGO Education Committee's Clinical Trials Management/Concepts Subcommittee. Thanks to Drs. Jubilee Brown, Ann Klopp, Joyce Liu, and Jyoti Mayadev for your contribution to this episode.
 
Moderator:
Kathryn Mills, MD

Speakers:
Jubilee Brown, MD
Ann Klopp, MD, PhD
Joyce Liu, MD, MPH
Jyoti Mayadev, MD 

This is the last of the three-part podcast series, Keeping up with the Chemos on Mirvetuximab soravtansine.  Our multidisciplinary panel will discuss the challenges with patient monitoring while on Mirvetuximab soravtansine. The panel discusses personal clinical experiences and lessons learned.  When to dose adjust and hold or even discontinue Mirvetuximab soravtansine. Once again, the session ends with take home points for patient monitoring while on Mirvetuximab soravtansine.  

2022-2023 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:
Tracilyn Hall, MD
Judith A. Smith, B.S., Pharm.D, BCOP, CPHQ

Speakers:
Julia Canestraro, OD, FAAO 
Karen Lyle, PA-C
Kathleen Moore, MD